Shandong Teamgene Technology Toekomstige groei
Future criteriumcontroles 4/6
Shandong Teamgene Technology is forecast to grow earnings and revenue by 45.4% and 17.5% per annum respectively. EPS is expected to grow by 45.3% per annum. Return on equity is forecast to be 12.4% in 3 years.
Belangrijke informatie
45.4%
Groei van de winst
45.3%
Groei van de winst per aandeel
| Food winstgroei | 22.1% |
| Inkomstengroei | 17.5% |
| Toekomstig rendement op eigen vermogen | 12.4% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 30 Apr 2024 |
Recente toekomstige groei-updates
Geen updates
Recent updates
The Returns On Capital At Shandong Teamgene Technology (SHSE:603151) Don't Inspire Confidence
Oct 16
We Think That There Are More Issues For Shandong Teamgene Technology (SHSE:603151) Than Just Sluggish Earnings
May 03Shandong Teamgene Technology (SHSE:603151) May Have Issues Allocating Its Capital
Mar 05Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 3,182 | 199 | N/A | 133 | 1 |
| 12/31/2025 | 2,502 | 173 | 126 | 126 | 2 |
| 12/31/2024 | 2,181 | 123 | 244 | 238 | 1 |
| 9/30/2024 | 2,121 | 59 | -286 | -163 | N/A |
| 6/30/2024 | 1,804 | 63 | -445 | -254 | N/A |
| 3/31/2024 | 1,669 | 81 | -282 | -83 | N/A |
| 12/31/2023 | 1,647 | 84 | -315 | -54 | N/A |
| 9/30/2023 | 1,611 | 102 | -325 | -75 | N/A |
| 6/30/2023 | 1,640 | 108 | -190 | -11 | N/A |
| 3/31/2023 | 1,711 | 117 | -123 | 29 | N/A |
| 12/31/2022 | 1,658 | 120 | -113 | 59 | N/A |
| 9/30/2022 | 1,631 | 135 | -50 | 128 | N/A |
| 12/31/2021 | 2,035 | 146 | 34 | 132 | N/A |
| 12/31/2020 | 1,724 | 112 | 146 | 169 | N/A |
| 12/31/2019 | 1,005 | 53 | 75 | 79 | N/A |
| 12/31/2018 | 1,160 | 44 | -2 | 13 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: 603151's forecast earnings growth (45.4% per year) is above the savings rate (2.9%).
Winst versus markt: 603151's earnings (45.4% per year) are forecast to grow faster than the CN market (25.8% per year).
Hoge groeiwinsten: 603151's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: 603151's revenue (17.5% per year) is forecast to grow faster than the CN market (14% per year).
Hoge groei-inkomsten: 603151's revenue (17.5% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: 603151's Return on Equity is forecast to be low in 3 years time (12.4%).